Xi An Hengtong Guanghua Pharmaceutical Co., Ltd. Enterprise Products

Hengtong Guanghua Company is the only enterprise in China pharmaceutical industry that uses space biotechnology for technological innovation. The company's industrial focus lies in the research and development and production of human immune-enhancing drugs and veterinary antibiotics. The overall equipment automation control level of the enterprise has reached the world-class level, with the highest equipment level, environmental protection standards, the highest degree of automation and the most advanced technology, and has passed the national GMP certification in an all-round way.

The company's leading product, tylosin, is the largest animal antibiotic in the world. As one of the four major pharmaceutical feed additives, it has the characteristics of safety, high efficiency and no residue. The quality t meets the standard of British Pharmacopoeia Bp(v)98.

1999165438+1On October 20th, the tylosin strain "Taylor Star" boarded China's first manned experimental spacecraft "Shenzhou". After a 2 1 hour space journey, the ONA of the strain was mutated and recombined, and the bioavailability of the new strain was higher, thus making the tylosin in China reach the advanced level in the world. The second phase of the 200-ton tylosin project, with an investment of 300 million yuan, is a national "863" key project, a national special planning project for high-tech industries by the State Economic and Trade Commission, and a national key project for investment in fixed assets in the industrial and commercial fields.